The calculator uses information from the UK-PBC Research Cohort to estimate the risk (expressed in percentage) that a PBC patient established on treatment with Ursodeoxycholic acid (UDCA) will develop liver failure requiring liver transplantation within 5, 10 or 15 years from diagnosis.
The score may be used to identify high-risk patients for closer monitoring and second-line therapies, as well as low-risk patients who could potentially be followed-up in primary care.
The app is available here
